Cognitive changes in sporadic Parkinson's disease - A cliniconeuropathological correlation;Kognitive veränderungen bei spontan auftretendem morbus Parkinson - Klinisch-neuropathologische korrelation

Nervenheilkunde

Volumn 24, Issue 2, 2005, Pages 129-136

  Braak, Heika ^a   Rub U ^a   Del Tredici, K ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Dementia; Lewy bodies Lewy neurites; Parkinson's disease; Synucleinopathies

Indexed keywords

AUTOPSY; BRADYKINESIA; CLINICAL FEATURE; COGNITIVE DEFECT; CORRELATION ANALYSIS; DEMENTIA; DISEASE COURSE; HUMAN; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; PARKINSON DISEASE; REVIEW; RIGOR; SYMPTOM; TREMOR;

EID: 17044423402     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629940     Document Type: Review

References (62)

1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease. An 8-year prospective study. Arch Neurol 2003; 60: 387-92.
2. Albin RL, Young AB, Peney JB. The functional anatomy of disorders of the basal ganglia. Trends Neurosci 1995; 18: 63-4.
3. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, »prefrontal,« and »limbic« functions. Progr Brain Res 1990; 85: 119-46.
4. Apaydin H, Ahlskog E, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology. Arch Neurol 2002; 59: 102-12.
5. Bortz J, Lienert GA, Boehnke K. Verteilungsfreie Methoden in der Biostatistik. Berlin: Springer 1990.
6. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59.
7. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 2000; 247 (suppl. 2): 3-10.
8. Braak H, Del Tredici K. Presymptomatic and symptomatic stages of inclusion body pathology in Parkinson's disease. In: Schmidt W, Reith M (eds). Dopamine and Glutamate in Psychiatric Disorders. Totowa, NJ: The Humana Press 2004; 469-96.
9. Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J, Jellinger K. Amygdala pathology in Parkinson's disease. Acta Neuropathol 1994; 88: 493-500.
10. Braak H, de Vos RAI, Jansen ENH, Bratzke HJ, Braak E. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Progr Brain Res 1998; 117: 267-85.
11. Braak H, Rüb U, Sandmann-Keil D, Gai, WP, de Vos RAI, Jansen Steur ENH, Arai K, Braak E. Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol 2000; 99: 489-95.
12. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-210.
13. Braak H, Rüb U, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003; 110: 517-36.
14. Braak H, Del Tredici K, Braak E. Spectrum of pathology. In: Petersen RC (ed). Mild cognitive impairment. Aging to Alzheimer's disease. Oxford: University Press 2003; 149-89.
15. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-34.
16. Chan-Palay V. Depression and dementia in Parkinson's disease. Adv Neurol 1993; 60: 438-46.
17. Cole NB, Murphy DD. The cell-biology of alpha-synuclein: a sticky problem? Neuromol Med 2002; 1: 95-109.
18. Colosimo C, Hughes AJ, Kilford L, Lees AJ. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 852-6.
19. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alteration in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999; 58: 376-88.
20. Del Tredici K, Braak H. Idiopathic Parkinson's disease: Staging an α-synucleinopathy with a predictable pathoanatomy. In: Kahle P, Haass C (eds). Molecular Mechanisms in Parkinson's Disease. Georgetown, TX: Landes Bioscience 2004; 1-32.
21. Del Tredici K, Rüb U, de Vos RAI, Bohl JRE, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002; 61: 413-26.
22. Dickson DW. Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol 2001; 14: 423-32.
23. Doty RL. Olfaction. Ann Rev Psych 2001; 52: 423-52.
24. Dubois B, Pillon B. Dementia in Parkinson's disease. In: Wolters EC, Scheltens P, Berendse HW (eds). Mental Dysfunction in Parkinson's Disease. Utrecht: Netherlands Academic Pharmaceutical Productions 1999; 165-76.
25. Folstein MF, Folstein SE, McHugh PR. »Mini-mental state.« A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
26. Galvin JE, Lee VMY, Trojanowski JQ. Synucleinopathies. Clinical and pathological implications. Arch Neurol 2001; 58: 186-90.
27. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999; 56: 33-9.
28. German DC, Manaye KF, White CL. Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 1992; 32: 667-76.
29. Golbe LI. Alpha-synuclein and Parkinson's disease, Mov Disord 1999; 14: 6-9.
30. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord 2003; 18: 364-72.
31. Heimer L, de Olmos J, Alheid GF, Zaborszky L. »Perestroika« in the basal forebrain: Opening the border between neurology and psychiatry. Progr Brain Res 1991; 87: 109-65.
32. Huang XF, Törk I, Paxinos G. Dorsal motor nucleus of the vagus nerve: a cyto- and chemoarchitectonic study in the human. J Comp Neurol 1993; 330: 158-82.
33. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
34. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-8.
35. Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH, Spokes EG. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000; 54: 1596-1602.
36. Hyman BT, van Hoesen GW, Damasio AR. Memory-related systems in Alzheimer's disease: an anatomic study. Neurology 1990; 40: 1721-30.
37. nd edition. San Diego, London: Elsevier Academic Press 2004; 872-915.
38. Inzelberg R, Plotnik M, Flash T, Schechtman E, Shahar I, Korczyn AD. Switching abilities in Parkinson's disease. Adv Neurol 1996; 69: 361-9.
39. Jellinger KA. Morphological substrates of mental dysfunction in Lewy body disease: an update. J Neural Transm 2000; 59 (suppl): 185-212.
40. Jellinger KA, Seppi K, Wenning GK, Poewe W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 2002; 109: 329-39.
41. Jensen PH, Gai WP. Alpha-synuclein. Axonal transport, ligand interaction, and neurodegeneration. In: Tolnay M. Probst A (eds). Neuropathology and Genetics of Dementia. New York: Kluwer Academic/Plenum 2001; 129-34.
42. Knopman DS, Boeve BF, Petersen RC. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc 2003; 78: 1290-1308.
43. Kövari E, Gold G, Herrmann FR et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol 2003; 106: 83-8.
44. Korczyn AD. Dementia in Parkinson's disease. J Neurol 2001; 248 (suppl 3): 1-4.
45. Kuusisto E, Parkkinen L, Alafuzoff I. Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein. ubiquitin, and p62. J Neuropathol Exp Neurol 2003; 62: 1241-53.
46. Lowe J. Lewy bodies. In: Calne DP (ed). Neurodegenerative Diseases. Philadelphia: Saunders 1994; 51-69.
47. Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord 2004; 19: 60-7.
48. Perry RH, Jaros EB, Irving D et al. What is the neuropathological basis of dementia associated with Lewy bodies? In: Perry RH, McKeith IG, Perry EK (eds). Dementia with Lewy bodies. Cambridge, New York: Cambridge University Press 1996; 212-23.
49. Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 1999; 22: 273-80.
50. Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001; 58: 1985-92.
51. Petersen RC, Morris JC. Clinical features. In: Petersen RC (ed). Mild Cognitive Impairment. Aging to Alzheimer's disease. Oxford: University Press 2003: 15-40.
52. nd edition. San Diego, London: Elsevier Academic Press 2004; 951-74.
53. nd edition. San Diego, London: Elsevier Academic Press 2004; 1198-1212.
54. Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the nun study. Ann Neurol 2002; 51: 567-77.
55. Saper CB. Diffuse cortical projection systems: Anatomical organization and role in cortical function. In: Plum F (ed). Handbook of Physiology, vol. 5. The Nervous System. Bethesda: Am Physiol Soc 1987; 169-210.
56. Thal DR, Del Tredici K, Braak H. Neurodegeneration in normal brain aging and disease. SAGE KE 2004; 23: 26.
57. Vertesi A, Lever JA, Molloy DW, Sanderson B, Tuttle I, Pokoradi L, Principi E. Standardized Mini-Mental State Examination. Use and interpretation. Can Fam Physician 2001; 47: 2018-23.
58. Wakabayashi K, Hansen LA, Masliah E. Cortical Lewy body-containing neurons are pyramidal cells. Laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32. Acta Neuropathol 1995; 89: 404-8.
59. Wolters EC, Francot CMJE. The concept of mental dysfunction in Parkinson's disease. In: Wolters EC, Scheltens P, Berendse HW (eds). Mental Dysfunction in Parkinson's Disease. Utrecht: Netherlands Academic Pharmaceutical Productions 1999; 35-48.
60. Woods SP, Tröster AI. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. J Intern Neuropsychol Soc 2003; 9: 17-24.
61. Zilles K. Architecture of the human cortex. In: Paxinos G, Mai JK (eds). The Human Nervous System, 2nd edition. San Diego, London: Elsevier Academic Press 2004; 997-1060.
62. Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC. The locus ceruleus and dementia in Parkinson's disease. Neurology 1993; 43: 986-91.